BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

SeqWright Announces the Addition of Illumina HiSeq 2000 to its Next Generation Sequencing Capabilities


8/18/2010 8:30:52 AM

HOUSTON, Aug. 17 /PRNewswire/ -- SeqWright Inc., a world-wide leader in custom genomic and molecular biology services, announced today that it has acquired the Illumina HiSeq 2000 Next Generation Sequencing System. Addition of the HiSeq 2000 platform enables SeqWright to perform the largest and most complex sequencing studies at the lowest possible cost to its customers. The ability to process increased numbers of samples and to decode larger and more complex genomes means that virtually any sequencing project is now achievable. SeqWright will utilize Illumina's efficient and scalable data analysis software to transform billions of bases of raw sequencing data into publishable, biologically meaningful results.

Addition of the Illumina HiSeq 2000 to SeqWright's already established Roche 454 GS FLX Titanium and AB SOLiD 4 next generation sequencing platforms, along with multiple available sequence capture and target enrichment technologies, enables SeqWright to offer its customers the very best in sequencing solutions. For target enrichment, SeqWright recently introduced its RainDance Technology capabilities as well as Certified Service Provider status for Agilent Sureselect. SeqWright is also an Authorized Service Provider for NimbleGen capture Arrays. With its proficiency in next generation genomics and a strong commitment to investing in next-gen technologies, SeqWright is proving to be a leader in the life science industry, with a wealth of experience and a comprehensive portfolio of services. SeqWright's primary focus is to offer customer-specific solutions while continuing to evaluate the market for the next advancement in Next Generation platforms.

About SeqWright

Based in Houston, TX, SeqWright Incorporated is recognized as an international leader in the field of contract genomic services, including next generation sequencing. For over fifteen years, SeqWright has provided state-of-the-art Molecular Biology and Genomic services, from small projects up to full clinical trials. SeqWright was recently awarded a license by the state of California to operate as a clinical laboratory. This license, along with CLIA certification, allows SeqWright to handle clinical samples from the vast majority of the United States. For additional information about SeqWright and its services, please visit www.seqwright.com.

SOURCE SeqWright, Inc.



Read at BioSpace.com

SeqWright
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES